[SP2-2]Amendment of the Act of the Safety of Regenerative Medicine related to in vivo gene therapy
○Keigo Sano(Office for Promotion of Regenerative Medicine, Research and Development Policy Division, Health Policy Bureau, Ministry of Health, Labour and Welfare)
Password required to view
Abstract password authentication.
The password was sent to all registrants in email.
The password was sent to all registrants in email.
